VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MGPI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MGPIMGP Ingredients, Inc.
$16.98$364M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMGPIFinancials

MGP Ingredients, Inc. (MGPI) Income Statement

30Y historyFree accessUpdated daily

Revenue and gross margin have trended down from $190.8M and 43.6% in 2024Q2 to $117.9M and 34.3% in 2026Q3, with operating margin turning deeply negative (-162.7%) in 2026Q1 due to impairment-driven losses.

Income StatementBalance SheetCash FlowRatios

MGPI Income Statement

Annual statement

MGPI Income Statement

MGP Ingredients, Inc. (MGPI) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Jun'11Jun'10Jun'09Jun'08Jul'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97Jun'96
Sales/Revenue487.01M536.38M703.63M836.52M782.36M626.72M395.52M362.75M376.09M347.45M318.26M327.6M313.4M323.26M334.33M247.91M201.97M275.98M392.89M367.99M322.48M275.18M270.67M192.37M214.53M229.24M231.88M216.1M223.3M224.7M194.6M
Revenue Growth %-15.87%-23.77%-15.89%6.92%24.83%58.45%9.04%-3.55%8.24%9.17%-2.85%4.53%-3.05%-3.31%34.86%22.75%-26.82%-29.76%6.77%14.11%17.19%1.66%40.7%-10.33%-6.42%-1.14%7.3%-3.22%-0.62%15.47%7.93%
Cost of Goods Sold318.24M336.97M417.31M531.81M529.05M427.75M296.71M286.21M292.49M271.43M252.98M269.07M284.97M302.02M309.31M225.04M171.43M310.08M388.66M321.94M277.26M249.94M245.77M202.11M193.32M212.06M197.46M187M200.6M199.7M176.3M
COGS % of Revenue-62.82%59.31%63.57%67.62%68.25%75.02%78.9%77.77%78.12%79.49%82.13%90.93%93.43%92.52%90.77%84.88%112.36%98.92%87.49%85.98%90.83%90.8%105.06%90.12%92.5%85.16%86.53%89.83%88.87%90.6%
Gross Profit168.77M199.41M286.32M304.71M253.31M198.97M98.81M76.53M83.6M76.02M65.28M58.53M28.43M21.24M25.02M22.88M30.54M-34.1M4.23M46.05M45.21M25.24M24.91M-9.74M21.2M17.18M34.42M29.1M22.7M25M18.3M
Gross Margin %34.65%37.18%40.69%36.43%32.38%31.75%24.98%21.1%22.23%21.88%20.51%17.87%9.07%6.57%7.48%9.23%15.12%-12.36%1.08%12.51%14.02%9.17%9.2%-5.06%9.88%7.5%14.84%13.47%10.17%11.13%9.4%
Gross Profit Growth %--30.35%-6.04%20.29%27.31%101.37%29.1%-8.45%9.98%16.44%11.53%105.88%33.86%-15.12%9.38%-25.1%189.57%-906%-90.81%1.86%79.13%1.34%355.72%-145.94%23.4%-50.07%18.27%28.19%-9.2%36.61%-38.8%
Operating Expenses445.36M294.02M211.89M156.1M104.34M72.6M44.56M29.29M33.45M33.11M23.31M25.68M20.1M26.44M25.97M21.98M23.29M26.09M33.88M18.89M22.84M18.61M9.62M-3.79M9.82M13.54M25.62M25.5M25.3M23.2M22.9M
OpEx % of Revenue-54.82%30.11%18.66%13.34%11.58%11.27%8.07%8.89%9.53%7.32%7.84%6.41%8.18%7.77%8.87%11.53%9.46%8.62%5.13%7.08%6.76%3.55%-1.97%4.58%5.91%11.05%11.8%11.33%10.32%11.77%
Selling, General & Admin138.18M115.9M121.9M129.61M104.34M88.93M44.56M29.29M33.45M33.11M26.69M25.68M20.1M26.2M26.54M21.16M20.71M21.4M24.23M20.32M23.81M19.32M20.34M13.62M14.69M13.54M12.11M11.9M11.4M9.2M9M
SG&A % of Revenue-21.61%17.32%15.49%13.34%14.19%11.27%8.07%8.89%9.53%8.39%7.84%6.41%8.11%7.94%8.53%10.25%7.75%6.17%5.52%7.38%7.02%7.51%7.08%6.85%5.91%5.22%5.51%5.11%4.09%4.62%
Research & Development0000000000916K748K1.62M2.47M2.34M0000000000000000
R&D % of Revenue----------0.29%0.23%0.52%0.76%0.7%----------------
Other Operating Expenses1.51M178.12M89.99M26.49M0-16.32M00003.38M0-1K-236K2K826K2.58M4.69M9.65M-1.43M-968K-707K-10.72M-17.4M-4.87M013.52M13.6M13.9M14M13.9M
Operating Income-276.59M-94.61M74.43M148.61M148.97M126.36M54.24M47.24M50.15M42.91M41.98M32.85M16.62M-5.2M-944K645K7.25M-79.01M-29.65M27.16M22.37M6.63M15.29M-5.95M11.38M3.64M8.79M3.6M-2.6M1.8M-4.6M
Operating Margin %-56.79%-17.64%10.58%17.77%19.04%20.16%13.71%13.02%13.33%12.35%13.19%10.03%5.3%-1.61%-0.28%0.26%3.59%-28.63%-7.55%7.38%6.94%2.41%5.65%-3.09%5.3%1.59%3.79%1.67%-1.16%0.8%-2.36%
Operating Income Growth %--227.13%-49.92%-0.24%17.89%132.97%14.82%-5.79%16.87%2.23%27.78%97.67%419.66%-450.74%-246.36%-91.11%109.18%-166.47%-209.17%21.41%237.41%-56.63%356.77%-152.32%212.78%-58.63%144.25%238.46%-244.44%139.13%-143.4%
EBITDA-251.26M-70.53M96.42M170.73M170.42M145.46M67.2M58.81M61.51M54.22M53.23M45.23M28.94M6.81M10.62M9.49M15.89M-67.06M-14.48M41.63M35.02M22.64M30.48M8.4M25.69M17.27M22.31M17.2M11.3M15.8M9.3M
EBITDA Margin %-51.59%-13.15%13.7%20.41%21.78%23.21%16.99%16.21%16.36%15.6%16.72%13.81%9.24%2.11%3.18%3.83%7.87%-24.3%-3.69%11.31%10.86%8.23%11.26%4.37%11.97%7.53%9.62%7.96%5.06%7.03%4.78%
EBITDA Growth %-846.45%-173.15%-43.53%0.18%17.16%116.44%14.26%-4.38%13.45%1.86%17.68%56.27%325.02%-35.9%11.97%-40.27%123.69%-363.2%-134.78%18.85%54.72%-25.74%262.92%-67.3%48.78%-22.61%29.7%52.21%-28.48%69.89%-51.81%
D&A (Non-Cash Add-back)25.33M24.09M21.99M22.11M21.45M19.09M12.96M11.57M11.36M11.31M11.25M12.38M12.32M12.01M11.57M8.84M8.63M11.95M15.17M14.47M12.65M16.01M15.2M14.35M14.31M13.63M13.52M13.6M13.9M14M13.9M
EBIT-277.85M-93.31M76.88M148.39M145.62M125.13M54.24M47.24M50.15M42.91M38.59M32.85M7.44M-5.4M2.81M2.99M-887K5.73M-79.01M-25.35M27.16M22.37M6.63M15.29M-5.95M11.38M3.64M8.79M3.6M-2.6M1.8M
Net Interest Income-9.22M-7.04M-8.44M-6.65M-5.45M-4.04M-2.27M-1.3M-1.17M-1.18M-1.29M-534K-816K-1.12M-868K0-358K-1.76M-2.9M-1.49M-964K-1.48M-1.39M-1.09M0-1.24M-1.35M000-2.6M
Interest Income0000000000000000000000000000000
Interest Expense9.22M7.04M8.44M6.65M5.45M4.04M2.27M1.3M1.17M1.18M1.29M534K816K1.12M870K358K1.76M2.9M1.49M964K1.48M1.39M1.09M1.09M1.24M1.35M1.35M1.1M400K2.6M2.6M
Other Income/Expense-10.48M-5.74M-5.98M-6.87M-8.79M-5.27M-1.64M-1.3M-1.17M9.85M2.74M5.57M9.32M-1.32M2.89M1.47M-1.89M-3.29M-2.9M6.06M5.32M-1.34M362K362K14.47M-1.01M-4.4M4.48M4.7M-1.1M4.8M
Pretax Income-287.07M-100.35M68.44M141.75M140.17M121.1M52.6M45.94M48.98M52.76M44.72M38.42M25.94M-6.52M1.94M-1.25M3.97M-81.91M-23.59M27.69M21.02M6.13M15.65M8.52M10.37M4.4M8.08M2.1M-3.7M200K-5.6M
Pretax Margin %-58.95%-18.71%9.73%16.94%17.92%19.32%13.3%12.66%13.02%15.18%14.05%11.73%8.28%-2.02%0.58%-0.5%1.97%-29.68%-6%7.52%6.52%2.23%5.78%4.43%4.83%1.92%3.49%0.97%-1.66%0.09%-2.88%
Income Tax-36.53M7.48M33.98M34.62M31.3M30.28M12.26M7.14M11.7M10.94M13.53M12.23M2.27M-714K318K68K-4.77M-12.79M-11.85M9.99M7.03M2.12M6.18M3.37M4.11M1.74M3.19M800K-1.5M100K-2.2M
Effective Tax Rate %12.72%-7.46%49.64%24.42%22.33%25%23.3%15.55%23.88%20.73%30.26%31.83%8.73%10.95%16.37%-5.46%-120.1%15.61%50.23%36.08%33.44%34.65%39.5%39.51%39.63%39.5%39.5%38.1%40.54%50%39.29%
Net Income-250.54M-107.81M34.66M107.47M109.46M91.31M40.34M38.79M37.28M41.82M31.18M26.19M23.68M-4.93M1.62M-1.31M8.74M-69.12M-11.74M17.7M13.99M4M9.47M5.15M6.26M2.66M4.89M1.3M-2.2M100K-3.4M
Net Margin %-51.44%-20.1%4.93%12.85%13.99%14.57%10.2%10.69%9.91%12.04%9.8%7.99%7.55%-1.52%0.49%-0.53%4.33%-25.05%-2.99%4.81%4.34%1.46%3.5%2.68%2.92%1.16%2.11%0.6%-0.99%0.04%-1.75%
Net Income Growth %-1555.04%-411.02%-67.75%-1.82%19.88%126.32%4%4.05%-10.85%34.12%19.06%10.63%580.32%-403.51%223.69%-115.03%112.64%-488.68%-166.35%26.46%249.53%-57.71%83.7%-17.65%135.3%-45.6%276.15%159.09%-2300%102.94%-203.03%
Net Income (Continuing)-250.54M-107.81M34.47M107.13M108.87M90.82M40.34M38.79M37.28M41.82M31.18M26.19M23.68M-5.81M1.62M18.94M-1.31M8.74M-69.12M-11.74M17.7M13.99M4M9.47M5.15M6.26M2.66M4.89M1.3M-2.2M100K
Discontinued Operations0000000000000878K00000000000000000
Minority Interest0-1.65M-1.62M-1.43M-1.08M-490K0000000000000000000000000
EPS (Diluted)-11.68-4.991.564.804.924.322.372.272.212.441.821.481.32-0.290.09-0.080.51-4.17-0.701.050.830.240.590.330.380.160.240.07-0.110.00-0.18
EPS Growth %-1638.81%-419.87%-67.5%-2.44%13.89%82.28%4.41%2.71%-9.43%34.07%22.97%12.12%555.17%-422.22%214.65%-115.39%112.23%-495.71%-166.67%26.51%245.83%-59.32%78.79%-13.16%137.5%-33.33%269.23%159.09%-102.44%-205.88%
EPS (Basic)--4.991.564.824.944.372.372.272.212.441.821.481.32-0.290.09-0.080.52-4.17-0.711.080.870.250.610.330.380.160.270.07-0.110.01-0.18
Diluted Shares Outstanding21.46M21.36M22.02M22.17M22.05M20.98M16.94M17.01M16.87M16.75M16.64M17.12M17.31M17.07M16.95M16.73M17.08M16.59M16.77M16.86M16.86M16.36M16.05M15.62M16.3M16.63M20M20M20M22.5M19.43M
Basic Shares Outstanding21.46M21.36M22.02M22.06M22M20.72M16.94M17.01M16.87M16.75M16.64M17.12M17.31M17.07M16.95M16.73M16.66M16.59M16.54M16.39M16.11M15.97M15.52M15.62M16.26M16.63M18.11M20M19.13M20M19.43M
Dividend Payout Ratio--30.67%9.93%9.73%10.97%20.29%17.67%14.75%41.56%6.63%4.15%3.83%-56.28%-10.2%--23.92%35.98%61.99%25.68%22.27%-45.9%17.48%----

Key Metrics

Growth RegimeDecelerating
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Volatile impairment-driven losses

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Contracting Across Consecutive Quarters

Based on reported quarterly figures, MGPI's revenue declined from $190.8M in 2024Q2 to $117.9M in 2026Q3, with year-over-year declines of roughly 9% to 24% across most recent periods.

The sustained year-over-year revenue contraction suggests softening demand or pricing pressure in MGPI's core spirits and ingredients businesses rather than a single transitory event. The data does not disaggregate volume from price, so it is unclear whether the decline reflects lower shipments or weaker realized pricing, which warrants further investigation. Investors should monitor whether the recent 2026Q3 rate of decline moderates, as continued contraction would challenge the durability of the revenue base.

Gross Margin Compressing From Peak Levels

Reported gross margin fell from 43.6% in 2024Q2 to 34.3% in 2026Q3, a decline of roughly nine percentage points that exceeds the drift seen at peers such as SAM at 45.6%.

The gross margin compression indicates that MGPI's cost of goods sold has risen faster than its selling prices, consistent with reduced pricing power or unfavorable input and absorption dynamics. Relative to The Boston Beer Company's 45.6% gross margin, MGPI now sits at a meaningful discount, which may point to a less differentiated product mix. Margin recovery would be the key indicator to watch for whether the cost pressure is cyclical or structural.

Reported Earnings Distorted by Impairment Charges

MGPI's 2026Q1 operating loss of $173.2M and net loss of $134.8M, against revenue of $106.4M, appear driven by non-recurring charges rather than core operating performance, with EPS swinging to -$6.30.

The magnitude of the 2026Q1 and 2025Q4 losses relative to revenue suggests large non-cash or non-operating items, though the supplied data does not itemize them, so their nature cannot be confirmed. Excluding these periods, quarterly operating margins have generally remained positive in the mid-single to mid-teens range. Investors should treat reported EPS with caution and focus on normalized operating income until the composition of these charges is clarified.

Operating Deleverage as Gross Profit Falls

Gross profit declined from $83.2M in 2024Q2 to $40.5M in 2026Q3 while SG&A remained comparatively stable near $26M to $35M, indicating that fixed overhead is absorbing a larger share of a shrinking gross profit base.

Because SG&A has not contracted in step with gross profit, operating margin has been compressed more sharply than gross margin alone would imply. This pattern suggests limited near-term ability to flex the cost base in response to the revenue decline. Management's ability to reduce overhead without impairing commercial capacity is a key question for future quarters.

Bear Case Centers on Recurring Write-Downs

The strongest bear argument is that repeated large losses in 2025Q4 and 2026Q1 may reflect recurring asset write-downs, with the peer comparison showing CODI operating at a 2.3% margin and negative net margin.

Short-sellers would likely argue that a pattern of large charges against a declining revenue base signals impaired asset values that may not be fully captured in the reported figures, though this cannot be confirmed from the supplied data. The absence of reported R&D and minimal stock-based compensation simplify the earnings picture but do not resolve the question of charge recurrence. Continued revenue contraction combined with the possibility of further impairments would warrant a more cautious view of the income statement trajectory.

MGPI — Frequently Asked Questions

Quick answers to the most common questions about buying MGPI stock.

What was MGP Ingredients, Inc.'s (MGPI) revenue in 2025?

For fiscal year 2025, MGP Ingredients, Inc. (MGPI) reported total revenue of $536.4M. This represents a 175.6% increase compared to $194.6M in 1996.

Is MGP Ingredients, Inc. (MGPI) profitable?

MGP Ingredients, Inc. (MGPI) reported a net loss of $107.8M for the fiscal year ending 2025.

What is MGP Ingredients, Inc.'s operating profit margin?

MGP Ingredients, Inc. (MGPI) reported an operating income of $-94.6M, resulting in an operating profit margin of -17.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is MGP Ingredients, Inc.'s gross profit and gross margin?

MGP Ingredients, Inc. (MGPI) generated $199.4M in gross profit for the year, representing a gross profit margin of 37.2%. This demonstrates the company's core pricing power and production efficiency.